Forty-two randomised controlled trials with 58 treatment arms were included in the review (reportedly including 2,808 patients). The quality of the trials was generally low; 5.6% reported allocation concealment, 9.3% had blinded outcome assessors, and 35.2% used intention-to-treat analyses. Mean intervention duration ranged from eight to 108 weeks; mean intensity ranged from 4.5 to 27 METs (hours per week).
Compared with placebo, structured exercise interventions were associated with statistically significant greater reductions in systolic blood pressure (WMD -2.42, 95% CI -4.39 to -0.45; 31 studies) and diastolic blood pressure (WMD -2.23, 95% CI -3.21 to -1.25; 29 trials). A slight increase in high-density lipoprotein cholesterol was observed with the intervention groups over placebo groups, although this difference was of borderline statistical significance (WMD 0.04, 95% CI 0.02 to 0.07; 36 trials). No significant differences between the groups were observed for changes in levels of low-density lipoprotein cholesterol (25 studies).
High levels of heterogeneity were shown in these meta-analyses (Ι² range: 62.4 to 94.3%); this heterogeneity was partially explained by age, dietary co-intervention and the duration/intensity of the exercise. Evidence of publication bias was shown for some outcomes, including systolic blood pressure, and both low-density and high-density lipoprotein cholesterol. Further results were reported in the review.